 FREMONT, Calif., Nov. 16, 2020 GLOBE NEWSWIRE -- Zosano Pharma Corporation NASDAQ:ZSAN, a clinical-stage biopharmaceutical company, today announced that the Compensation Committee of the Board of Directors granted a stock option to purchase 100,000 shares of Zosanos common stock to a new employee as an inducement award. 